FIELD: organic chemistry. SUBSTANCE: invention relates to the novel compound - 6-nitro-3H-quinazolone-4-yl-3-acetic acid monoethanolammonium salt of the formula (I) 
eliciting antioxidant and anti-ischemic activities and can be used in medicine. EFFECT: new compound indicated above, valuable pharmacological properties. 4 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 6-NITRO-3H-QUINAZOLON-4-YL-3-ACETIC ACID SODIUM SALT HAVING ANTIOXIDANT AND ISCHEMIC ACTIVITIES | 1997 |
|
RU2146249C1 |
| 1-(β-PHENYLETHYL)-4-(PARA-DIMETHYLAMINOBENZYLIDENEAMINO)- -1,2,4-TRIAZOLIUM BROMIDE SHOWING ANTIOXIDANT, ANTI-ISCHEMIC, β-ADRENOBLOCKING, UTEROTONIC AND DECREASING INTRAOCULAR PRESSURE EFFECTS | 1997 |
|
RU2136669C1 |
| COMBINED DRUG FOR PRIMARY NEUROPROTECTION | 2017 |
|
RU2636616C1 |
| METHOD OF CONSERVATIVE TREATMENT OF CHILDREN WITH RENAL DYSPLASIA | 1997 |
|
RU2150941C1 |
| CEREBRAL PROTECTIVE AND STRESS-PROTECTIVE MEDICINAL AGENT "NOOTRIL" AS INJECTION SOLUTION | 2003 |
|
RU2268711C2 |
| METHOD OF TREATING OCCLUDING INJURIES OF CORNEAL AND OPTIC-NERVE VESSELS | 1995 |
|
RU2122384C1 |
| 1-PENTYL-4-(PARA-METHOXYBENZYLIDENEAMINO)-1,2,4-TRIAZOLIUM BROMIDE ELICITING SPASMOLYTIC ACTIVITY | 1997 |
|
RU2131422C1 |
| METHOD FOR PREVENTING SUBEPITHELIAL FIBROPLASIA FROM OCCURRING AFTER PHOTOREFRACTION KERATECTOMY | 2003 |
|
RU2272621C2 |
| LYSINIUM 3-METHYL-1,2,4-TRIASOLYL-5-THIOACETATE WITH NEUROPROTECTIVE, NOOTROPIC, CARDIOPROTECTIVE, ENDOTHELIOTROPIC, ANTI-ISCHEMIC, ANTIOXIDANT, ANTI-INFLAMMATORY AND ANTIHYPOXIC EFFECT AND LOW TOXICITY | 2007 |
|
RU2370492C2 |
| COMBINED DRUG OF ANXIOLITHIC, STRESS-PROTECTOR, NOOTROPIC AND ANTIOXIDANT ACTION | 2016 |
|
RU2625754C1 |
